Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC) Meeting Abstract


Authors: Reinmuth, N.; Popat, S.; Paz-Ares, L.; Knowles, E.; Hatswell, A.; McLean, T.; Adrian, S.; Gaumond, B.; Vioix, H.; Paik, P. K.
Abstract Title: Health utility with tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC)
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S985
End Page: S986
Language: English
ACCESSION: WOS:000700527702271
DOI: 10.1016/j.annonc.2021.08.1858
PROVIDER: wos
Notes: Meeting Abstract: 1255P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    257 Paik